Valuation: Stem Cells Spin S.A.

Market Cap	18.19M 4.89M 4.23M 3.95M 3.62M 6.81M 465M 6.92M 46.34M 233M 18.36M 17.96M 771M	P/E 2024	-15.6x	P/E 2025	-31.9x
Enterprise Value	18.27M 4.91M 4.25M 3.97M 3.64M 6.85M 468M 6.96M 46.55M 234M 18.45M 18.04M 775M	EV / Sales 2024	151x	EV / Sales 2025	257x
Free-Float	19.04%	Yield 2024 *	-	Yield 2025	-

* Estimated data More valuation ratios

Latest news : Stem Cells Spin S.A.

05-15	Stem Cells Spin S.A. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
02-15	Stem Cells Spin S.A. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI
11-13	Stem Cells Spin S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
14/08/25	Stem Cells Spin S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
13/05/25	Stem Cells Spin S.A. Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
13/02/25	Stem Cells Spin S.A. Reports Earnings Results for the Full Year Ended December 31, 2024	CI
13/02/25	Stem Cells Spin S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2024	CI
14/08/24	Stem Cells Spin S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	CI
15/05/24	Stem Cells Spin S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
14/02/24	Stem Cells Spin S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	CI
14/02/24	Stem Cells Spin S.A. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	CI
14/11/23	Stem Cells Spin S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
14/08/23	Stem Cells Spin S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI

More news

Managers and Directors: Stem Cells Spin S.A.

Manager	Title	Age	Since
Adam Symber CEO	Chief Executive Officer	45	31/12/2016

Director	Title	Age	Since
Marek Andrzej Cegielski BRD	Director/Board Member	74	27/06/2022
Andrzej Jan Trznadel BRD	Director/Board Member	64	-
Piotr Okoniewski BRD	Director/Board Member	-	14/03/2022

More insiders

Other Biotechnology & Medical Research

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
STEM CELLS SPIN S.A.	+10.00%	-10.20%	+22.91%	+25.71%	4.89M
LONZA GROUP AG	+0.99%	+1.78%	+5.07%	+16.49%	49.47B
REVOLUTION MEDICINES, INC.	+3.71%	+9.40%	+486.14%	+579.98%	43.97B
BEONE MEDICINES AG	+5.60%	+10.21%	+20.85%	+81.78%	39.6B
IQVIA HOLDINGS INC.	+2.70%	+1.57%	+32.71%	+9.07%	39.29B
CELLTRION, INC.	+2.21%	+6.75%	+20.20%	+54.40%	32.43B
ASCENDIS PHARMA A/S	+2.23%	+4.71%	-	-	16.84B
MEDPACE HOLDINGS, INC.	+0.97%	+2.35%	+35.99%	+124.45%	16.49B
EUROFINS SCIENTIFIC SE	-0.11%	+2.41%	+5.03%	+20.47%	14.01B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	+0.75%	+15.04%	+79.84%	+29.70%	12.77B
Average	+2.90%	+4.67%	+78.75%	+104.67%	26.49B
Weighted average by Cap.	+2.54%	+6.10%	+105.13%	+138.67%

See all sector performances

Stem Cells Spin SA is a Poland-based company. It is primarily engaged in biotechnology research. The Company is focused on development, production, marketing and sale of natural regenerative products for the dermocosmetic and veterinary care markets.

Employees

Sector

Biotechnology & Medical Research

Calendar

08-14 Earnings release - Q2 2026

More about the company

Quotes

Date	Price	Change	Volume
06/08/26	PLN 0.4400	+10.00%	2,575
05/08/26	PLN 0.4000	-20.00%	10,433
04/08/26	PLN 0.5000	0.00%	100
03/08/26	PLN 0.5000	+2.04%	810

End-of-day quote Warsaw S.E.

More quotes

Income Statement and Estimates

More financial data

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States

Canada

End-of-day quote Warsaw S.E. Other stock markets 06/08/2026			5-day change	1st Jan Change
0.4400 ^PLN	+10.00%		-10.20%	+8.37%

1 day	+10.00%
1 week	-10.20%
Current month	-10.20%
1 month	+10.00%
3 months	+7.32%
6 months	+7.32%
Current year	+8.37%

1 week	0.4	0.5
1 month	0.37	0.54
Current year	0.33	0.54
1 year	0.28	0.54
3 years	0.14	0.82
5 years	0.14	1.12
10 years	0.14	2.04

	2024	2025
Net sales	54.28K 14.59K 12.62K 11.79K 10.81K 20.34K 1.39M 20.66K 138K 696K 54.8K 53.6K 2.3M	65.74K 17.67K 15.29K 14.28K 13.1K 24.63K 1.68M 25.02K 167K 843K 66.36K 64.91K 2.79M
Net income	-520K -140K -121K -113K -104K -195K -13.31M -198K -1.33M -6.67M -525K -514K -22.06M	-526K -141K -122K -114K -105K -197K -13.45M -200K -1.34M -6.74M -531K -519K -22.28M
Net Debt	69.28K 18.63K 16.11K 15.05K 13.8K 25.96K 1.77M 26.37K 177K 888K 69.94K 68.41K 2.94M	84.58K 22.74K 19.67K 18.37K 16.85K 31.69K 2.16M 32.2K 216K 1.08M 85.39K 83.52K 3.59M

Stem Cells Spin S.A. Share Price

Stocks

SCS

PLSTCLS00013

Biotechnology & Medical Research

Valuation: Stem Cells Spin S.A.

Chart: Stem Cells Spin S.A.

Latest news : Stem Cells Spin S.A.

Quotes and Performance

Course Extremes

Managers and Directors: Stem Cells Spin S.A.

Other Biotechnology & Medical Research

Financials

Company Profile

Quotes

Income Statement and Estimates